- ►diegori.it [PDF] BM Brenner, ME Cooper, D de Zeeuw, WF … - The New England journal of medicine, 2001 - nejm.highwire.org Methods A total of 1513 patients were enrolled in this randomized, double-blind
study comparing losartan (50 to 100 mg once daily) with placebo, both taken in
addition to conventional antihypertensive treatment (calcium-channel ... Cited by 3529 - Related articles - BL Direct - All 25 versions
E Ritz, SR Orth - New England Journal of Medicine, 1999 - content.nejm.org In the not-so-distant past, type 2 diabetes mellitus was thought to be a
relatively benign condition, at least in the elderly, with relatively little
effect on life expectancy or renal function. 1 It has now become obvious ... Cited by 408 - Related articles - BL Direct - All 5 versions
C Arauz-Pacheco, MA Parrott, P Raskin - Diabetes Care, 2002 - Am Diabetes Assoc Hypertension is an extremely common comorbidity of diabetes, affecting 20–60%
of people with diabetes. Hypertension is also a major risk factor for
cardiovascular events, such as myocardial infarction and stroke, as well as ... Cited by 303 - Related articles - BL Direct - All 10 versions
MW Taal, BM Brenner - Kidney international, 2000 - nature.com Received 31 August 1999; Revised 23 November 1999; Accepted 24 November 1999. ... Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II
antagonists. In landmark clinical trials, pharmacological inhibition of the ... Cited by 290 - Related articles - BL Direct - All 4 versions
- ►annals.org S Vijan, RA Hayward - Annals of internal medicine, 2003 - Am Coll Physicians Background: Hypertension in patients with type 2 diabetes mellitus is a
prevalent condition that leads to substantial morbidity and mortality. ...
Purpose: To evaluate the goals and optimal agents for treatment of ... Cited by 186 - Related articles - BL Direct - All 11 versions
- Free from Publisher K Rossing, PK Christensen, BR Jensen, HH … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We performed a randomized double-blind crossover
study of 2 months treatment with candesartan cilexetil 8 mg once daily and
placebo in addition to previous antihypertensive treatment. We included 18 ... Cited by 182 - Related articles - BL Direct - All 5 versions
P Ruggenenti, A Perna, G Gherardi, R Benini, … - American Journal of Kidney Diseases, 2000 - Elsevier The Ramipril Efficacy in Nephropathy (REIN) study found that
angiotensin-converting enzyme (ACE) inhibitors effectively decreased
proteinuria, glomerular filtration rate (GFR) decline (ΔGFR), and ... Cited by 130 - Related articles - BL Direct - All 2 versions
A Zanchetti, LM Ruilope - Journal of hypertension, 2002 - pdfs.journals.lww.com Findings Evidence that association of type-2 diabetes with hypertension markedly
increases cardiovascular and renal risk is incontrovertible: even blood pressure
values in the high-normal range represent a more relevant risk than in non- ... Cited by 128 - Related articles - BL Direct - All 5 versions
- ►dm2nb.ca [PDF] M Rahman, S Pressel, BR Davis, C Nwachuku, … - Archives of internal medicine, 2005 - archinte.highwire.org Methods We conducted post hoc analyses of the Antihypertensive and
Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertensive
participants 55 years or older with at least 1 other coronary heart disease ... Cited by 133 - Related articles - BL Direct - All 11 versions
WF Keane - American Journal of Kidney Diseases, 2000 - Elsevier In patients with essential hypertension and in those with diabetes mellitus, the
presence of increased amounts of urinary protein or albumin has been shown to be
an important and independent risk for an increased incidence of ... Cited by 110 - Related articles - BL Direct - All 7 versions
